CSTL Similar Chart Price Prediction
The price of CSTL is predicted to go up -26.67%, based on the high correlation periods with ATNF. The similarity of these two price pattern on the periods is 94.17%.
CSTL
ATNF
Down: -26.67%Similarity: 94.17%
CSTL Revenue Forecast
CSTL EPS Forecast
CSTL FAQs
What is revenue forecast for next quarter？
CSTL Analyst's Forecast
Paul Knight
Keybanc
Buy
Price Target
$28 → $36
Upside
+15.57%
KeyBanc analyst Paul Knight raised the firm's price target on Castle Biosciences to $36 from $28 and keeps an Overweight rating on the shares. While the determination of coverage for the SCC test will remain a focus, the firm notes the company continues to expand volume for other tests, with growth in IDgenetix and TissueCypher. Strength in these other tests contributed to the strong results for the quarter, as well as the increase in revenue guidance, KeyBanc adds.
Catherine Ramsey
Baird
Buy
Price Target
$37 → $39
Upside
+25.2%
Kyle Mikson
Canaccord Genuity
Strong Buy
Price Target
$35 → $42
Upside
+24.33%